Moreover, metallic nanoparticles, such as gold nanoparticles conjugated with p53, are being tested to target specific cancer cells, like ovarian cancer cells, by exploiting overexpressed surface receptors such as EGFR. The gene discussed is TP53; the disease is cancer.